32 Results for "

Smac

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "Smac" in MCE Product Catalog:

Cat. No.: HY-RS25999
Research Areas:  

Others

Diablo Rat Pre-designed siRNA Set A contains three designed siRNAs for Diablo gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS03762
Research Areas:  

Others

DIABLO Human Pre-designed siRNA Set A contains three designed siRNAs for DIABLO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19505
Research Areas:  

Others

Diablo Mouse Pre-designed siRNA Set A contains three designed siRNAs for Diablo gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-161473
Target:  

Apoptosis

Research Areas:  

Cancer

Apoptosis inducer 16 (Compound 3) is a bivalent Smac mimic that can effectively bind to BIR2 and BIR3, and exhibits cancer cell (apoptosis) inducing activity .
loading...
    loading...
Cat. No.: HY-138059A
Purity:  98.57%
Target:  

IAP Apoptosis

Research Areas:  

Cancer

SM-433 hydrochlorid, a Smac mimetic, function as inhibitor of inhibitor of apoptosis proteins (IAPs). SM-433 hydrochlorid exhibits strong binding affinity XIAP BIR3 protein with an IC50<1 μM (patent WO2008128171A2) .
loading...
    loading...
Cat. No.: HY-N0732R
CAS No.: 37905-08-1
Jolkinolide B (Standard) is the analytical standard of Jolkinolide B (HY-N0732). This product is intended for research and analytical applications. Jolkinolide B is a bioactive diterpene isolated from the roots of Euphorbia fischeriana Steud with oral activity. Jolkinolide B downregulates XIAP, cIAP1, cIAP2, and phosphorylated Akt, upregulates Smac, activates caspase-3 and caspase-9, and inhibits NF-κB, TGFβ/smad3 and JAK/STAT3 pathways. Jolkinolide B exerts comprehensive biological effects including inducing cancer cell apoptosis, suppressing inflammatory responses, improving lung function, alleviating hepatic steatosis and eliminating intracellular Mycobacterium tuberculosis. Jolkinolide B can be used for the research of leukemia, histiocytic lymphoma, asthma, metabolic dysfunction-associated steatotic liver disease and tuberculosis .
loading...
    loading...
Cat. No.: HY-P82248
Synonyms: Smac; DFNA64; DIABLO; Smac3

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P82248A
Synonyms: Smac; DFNA64; DIABLO; Smac3

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P73416
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: DIABLO; Second Mitochondria-Derived Activator Of Caspase; Diablo IAP-Binding Mitochondrial Protein; DIABLO-S; Smac; FLJ25049; Direct IAP-Binding Protein With Low PI; FLJ10537; Diablo Homolog, Mitochondrial; Diablo, IAP-Binding Mitochondrial Protein; DFNA6
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-16591R
CAS No.: 1260251-31-7
Synonyms: TL32711 (Standard)
Research Areas:  

Infection Cancer

Birinapant (Standard) is the analytical standard of Birinapant (HY-16591). This product is intended for research and analytical applications. Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively. Birinapant (TL32711) induces the autoubiquitylation and proteasomal degradation of cIAP1 and cIAP2 in intact cells, which results in formation of a RIPK1: caspase-8 complex, caspase-8 activation, and induction of tumor cell death. Birinapant (TL32711) targets TRAF2-associated cIAPs and abrogates TNF-induced NF-κB activation.
loading...
    loading...
Cat. No.: HY-181533
Research Areas:  

Cancer

IAP ligand 9 is an ASX-series, non-peptidic SMAC mimetic and IAP binder with high cell permeability. IAP ligand 9 selectively targets cIAP1-BIR3, XIAP-BIR3, exhibits extremely weak binding affinity for XIAP-BIR2, with a KD of 100 nM for cIAP1-BIR3 and 10 nM for XIAP-BIR2. IAP ligand 9 can be used to synthesize IAP-recruiting protein degraders (IPD), and can calibrate the cell permeability and cellular-level target binding assays of the IPD molecule SNIPER (TEAD)-1 (HY-181607). IAP ligand 9 and its series of degraders can be used in the research of solid tumors such as malignant pleural mesothelioma associated with abnormal activation of the Hippo pathway .
loading...
    loading...
Cat. No.: HY-181532
Research Areas:  

Cancer

IAP ligand 8 is an ASX-series, non-peptidic SMAC mimetic and IAP binder with high cell permeability. IAP ligand 8 selectively targets cIAP1-BIR3, XIAP-BIR2 (with a KD of 15.8 nM for both). IAP ligand 8 serves as an IAP ligand moiety to synthesize IAP-recruiting protein degrader (IPD) (HY-181590). This IPD simultaneously forms two ternary complexes, cIAP1-A538-TEAD1 and XIAP-A538-TEAD1, and efficiently degrades TEAD1 via a dual E3 recruitment mechanism, while inducing the autodegradation of cIAP1. IAP ligand 8 and its series of degraders are applicable to targeted research on Hippo pathway-dysregulated cancers such as NF2-mutant mesothelioma .
loading...
    loading...